Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill.
Mandatory Credit: KENA BETANCUR/AFP/AFP via Getty Images
Stories this photo appears in:
Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pill
Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. The agreement with the Medicines Patent Pool, a United Nations-
